Jaipur

21 June 2015

MBA Pharmaceutical Management- Opening New Frontiers for a Vibrant Career in Pharmaceutical Industry

{ DOWNLOAD AS PDF }

ABOUT AUTHORS:
Saurabh Kumar Banerjee
Assistant Professor, School of Pharmaceutical Management,
The IIHMR University, Jaipur, Rajasthan, India
saurabh@iihmr.edu.in

Pablo Picasso the famous Spanish painter, poet and playwright once quoted-
“Our goals can only be reached through a vehicle of a plan, In which we must fervently believe, and upon which we must vigorously act.
There is no other route to success”

In our journey for achieving excellence in professional career, meticulous planning and correct decision making, plays the most vital role in transforming our dreams and aspirations into reality. This piece of writing is an effort to give the reader an insight into the world of Pharmaceutical Management and help them to take a rational decision on the basis of facts and evidence, so that they can pursue a successful professional career in the area of Pharmaceutical Management.

15 June 2015

Join MBA Programs at GISMA Business School, Germany

GISMA Business School, located in the heart of Hannover, Germany, is an international Business School offering campus-based business education to students from over 40 countries.
GISMA Business School is closely affiliated with Global University Systems (GUS), a consortium of 8 educational institutions, and is internationally accredited by AMBA. All courses at GISMA are taught in English, as the world’s foremost language for business and global communication. Our alumni come from as many as 40 different nations and are taught by professors of diverse cultural backgrounds.

ENQUIRE NOW >>

Our AMBA-accredited Programmes

1) MBA:
Become more than a business leader. Become a leader with a global viewpoint and practical experience – and an MBA from two highly regarded European business schools.
International Track, 18 months / Fast-Track, 12 months / Part-Time, 24 months

2) Masters in Management in International Business:
Become a leader with a Master degree from two highly regarded European business schools.
Full-Time, 12 months

Program Highlights
Flexible and career enhancing programmes that paves the way for a career in management.

Eligibility: Graduates, Postgraduates

ENQUIRE NOW >>

1 June 2015

PharmaTutor Magazine - June 2015 is released | Read online or Subscribe
20 May 2015

Faculty - Paramedical Lecturer / Professor in Client of 7 Colors Consultants

Our Client is one of the leader in Health Care /Medical Industry

Post: Faculty - Paramedical Lecturer / Professor
14 May 2015

Career as Area Business Manager in Jenome Biophar

We, Jenome Biophar recognize itself as a business organization with a mission, not merely an entity that exists to generate profit. This mission describes the road map towards reaching long-term objectives and establishing the organization's future vision. Moreover, it highlights the basis and values that control business conduct on all levels.
Moreover, a clear future vision accessible to all company employees is an important element in portraying the desired shape of the organization in the future and therefore inspires, motivates and improves performance. This is why we keep our mission and vision in mind and heart at all times.
We, Jenome Oncology, are dedicated to anticancer range of products. We are dealing in almost all chemotherapeutic range of products as well as we also deal in unique & specialized anti cancer range of products. We are the pioneer in our special range of products which we had launched first time in India.

Post: Area Business Manager
10 May 2015

Opportunity for Medical Representative in Leading Pharma Company Nextus Solution

Leading Pharma Company

Post: Medical Representative
30 April 2015

PharmaTutor Magazine - May 2015 is released | Read online and Subscribe
29 April 2015

Jaipur National University invites Faculty positions

Jaipur National University, Jaipur, a Private self- financed University, sponsored by Mahima Shiksha Samiti, Came into existence on October 22, 2007 through an Ordinance of the government of Rajasthan. Jaipur National University is one of the many institutions of the Seedling Group of educational Institutions of the Mahima Shiksha Samiti.

Invites applications for the posts of Professors/ Associate Professors/ Assistant Professors in the following disciplines

Post: Professors/ Associate Professors/ Assistant Professors
26 April 2015

MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS: AN EMERGING INFECTION

{ DOWNLOAD AS PDF }

ABOUT AUTHORS:
Suresh Rewar¹*, Dashrath Mirdha², Prahlad Rewar³
¹Department of pharmaceutics, Rajasthan University of Health Sciences, Jaipur, Rajasthan,
²Dr. Sarvepali Radhakrishnan Rajasthan Ayurved University, Jodhpur, Rajasthan, India
³Jawaharlal Nehru Medical College, Ajmer, Rajasthan, India
sureshrewar1990@gmail.com

ABSTRACT
A severe viral illness caused by a newly discovered coronavirus was first reported in the Middle East in 2012. The virus has since been named the Middle East respiratory syndrome coronavirus (MERS-CoV). MERS-CoV cases have been reported in several countries around the world in travelers from the Middle East., A substantial number of Indians live and work in Gulf countries. People from India also travel to Saudi Arabia as Pilgrims to Hajj. The illness has a high mortality rate. Limited human-to-human transmission has occurred including transmission to health care workers. The source of the virus remains unclear, but camels are a possible source. Since April 2012 and as of 20 February 2015, 1042 cases (including 419 deaths) of Middle East respiratory syndrome coronavirus (MERS-CoV) have been reported by local health authorities worldwide. Laboratory confirmation of MERS-CoV infections to date has largely been by real-time reverse transcription polymerase chain reaction (rRT-PCR) of lower respiratory tract specimens. Neither a vaccine nor effective therapy against the virus is available. Treatment consists of limited to supportive care, including mechanical ventilation for respiratory failure and/or hemodialysis in the setting of renal failure. Therapeutic modalities based on monoclonal antibodies (mAbs) have shown clinical success in the treatment of many diseases.
24 April 2015

MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS: AN EMERGING INFECTION

ABOUT AUTHORS:
Suresh Rewar¹*, Dashrath Mirdha², Prahlad Rewar³
¹Department of pharmaceutics, Rajasthan University of Health Sciences, Jaipur, Rajasthan,
²Dr. Sarvepali Radhakrishnan Rajasthan Ayurved University, Jodhpur, Rajasthan, India
³Jawaharlal Nehru Medical College, Ajmer, Rajasthan, India
sureshrewar1990@gmail.com

ABSTRACT
A severe viral illness caused by a newly discovered coronavirus was first reported in the Middle East in 2012. The virus has since been named the Middle East respiratory syndrome coronavirus (MERS-CoV). MERS-CoV cases have been reported in several countries around the world in travelers from the Middle East., A substantial number of Indians live and work in Gulf countries. People from India also travel to Saudi Arabia as Pilgrims to Hajj. The illness has a high mortality rate. Limited human-to-human transmission has occurred including transmission to health care workers. The source of the virus remains unclear, but camels are a possible source. Since April 2012 and as of 20 February 2015, 1042 cases (including 419 deaths) of Middle East respiratory syndrome coronavirus (MERS-CoV) have been reported by local health authorities worldwide. Laboratory confirmation of MERS-CoV infections to date has largely been by real-time reverse transcription polymerase chain reaction (rRT-PCR) of lower respiratory tract specimens. Neither a vaccine nor effective therapy against the virus is available. Treatment consists of limited to supportive care, including mechanical ventilation for respiratory failure and/or hemodialysis in the setting of renal failure. Therapeutic modalities based on monoclonal antibodies (mAbs) have shown clinical success in the treatment of many diseases.